The fund's investments in Novo Nordisk
At the end of 2022, the fund's investments in Novo Nordisk had a market value of 57.1 billion kroner or 5.8 billion dollar.
The production team on this episode were PLAN-B’s Nikolai Ovenberg and Niklas Figenschaug Johansen. Background research was done by Sigurd Brekke with additional input from our portfolio manager Gemma Game.
Last saved: 15/03/2023